LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on Express Scripts Holding Co. (NASDAQ: ESRX) (“Express Scripts”), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ESRX. The Company reported its first quarter fiscal 2018 operating and financial results on May 02, 2018. The pharmacy benefit manager outperformed top- and bottom-line expectations. Additionally, the Company provided guidance for the upcoming quarter. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Express Scripts Holding most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ESRX

Earnings Highlights and Summary

For the three months ended March 31, 2018, Express Scripts reported revenues of $24.77 billion compared to $24.65 billion in Q1 2017. The Company’s revenue numbers beat analysts’ estimates of $24.76 billion.

During Q1 2018, Express Scripts’ adjusted claims were down 3% to 340.1 million from the year ago same quarter, primarily due to the loss of certain public-sector clients in the core business during the previous year’s selling season, but were consistent with the Company’s guidance for the reported quarter.

Express Scripts announced a consolidated net income of $623.2 million, or $1.10 per diluted share, in Q1 2018 compared to $546.3 million, or $0.90 per diluted share, in Q1 2017.

Express Scripts’ consolidated adjusted earnings surged 33% to $1.77 per diluted share in the reported quarter compared to $1.33 per diluted share in Q1 2017, and were ahead of Wall Street’s estimates of $1.76 per share. Express Scripts’ earnings per diluted share, on a GAAP and an adjusted basis, were up on a y-o-y basis, primarily due to reduced shares outstanding and reduced income tax expenses.

During Q1 2018, Express Scripts’ adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) were up 3% to $1.54 billion compared to $1.50 billion in Q1 2017, primarily due to the inclusion of eviCore in the reported quarter, and supply chain initiatives, including a continued strong performance from the Company’s SafeGuardRx suite of solutions and a growth in its Accredo specialty pharmacy.

Core Business Review

During Q1 2018, Express Scripts’ Core Business’ total adjusted claims were down 3% to 284.0 million on a y-o-y basis, primarily due to the losses of certain public-sector clients. During the reported quarter, the Company generated $1.06 billion of core business adjusted EBITDA, representing a growth of 12% on a y-o-y basis.

Acquisition Update

On March 08, 2018, Express Scripts entered into an Agreement and Plan of Merger with Cigna Corp., whereby Cigna will acquire Express Scripts in a cash and stock transaction. The merger is expected to be completed by December 31, 2018.

Cash Matters

During Q1 2018, Express Scripts’ net cash flow provided by operating activities surged 51% to $1.51 billion on a y-o-y basis, due to a higher net income and changes in working capital primarily related to the timing of accounts payable payments.

For Q1 2018, Express Scripts repurchased a total of 5.4 million shares under its share repurchase program for an aggregate of $411.3 million. The Company has currently suspended its share repurchase program pursuant to the Merger Agreement with Cigna.

Outlook

Express Scripts is forecasting total adjusted claims to be in the range of 335 million to 345 million for the second quarter of the fiscal year 2018, of which 280 million to 290 million are attributable to the core business. The Company’s consolidated adjusted earnings per diluted share are estimated to be in the band of $2.18 to $2.22 for the upcoming quarter, which represents a growth of 26% to 28% on a y-o-y basis.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, Express Scripts’ stock marginally advanced 0.16%, ending the trading session at $76.21.

Volume traded for the day: 2.69 million shares.

Stock performance in the last month – up 0.67%; previous three-month period – up 1.01%; past twelve-month period – up 27.87%; and year-to-date – up 2.10%

After yesterday’s close, Express Scripts’ market cap was at $42.65 billion.

Price to Earnings (P/E) ratio was at 7.29.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 1.4% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501322

Stock Monitor: Balchem Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on FMC Corp. (NYSE: FMC), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=FMC. FMC reported its first quarter fiscal 2018 operating and financial results on May 02, 2018. The chemical producer outperformed top- and bottom-line expectations. Additionally, the Company updated its guidance for FY18. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Balchem Corporation (NASDAQ: BCPC), which also belongs to the Basic Materials sector as the Company FMC Corp. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=BCPC

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, FMC most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=FMC

Earnings Highlights and Summary

FMC reported revenue of $1.21 billion for its first quarter 2018, reflecting an increase of 103% compared to revenue of $596.0 million in Q1 2017. The Company’s reported numbers surpassed analysts’ estimates of $1.15 billion.

During Q1 2018, FMC’s adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) was $379.8 million, soaring 256% compared to $106.6 million in Q1 2017.

On a GAAP basis, FMC reported earnings of $267 million, or $1.96 per diluted share, in Q1 2018 compared to a net loss of $192 million, or $0.92 per diluted share, in Q1 2017. The Company’s reported quarter adjusted earnings zoomed 328% to $1.84 per diluted share versus $0.43 per diluted share in the prior year’s same quarter. FMC’s earnings numbers exceeded Wall Street’s estimates of $1.56 per share.

FMC’s Segment Results

During Q1 2018, the Agricultural Solutions segment reported revenue of $1.11 billion, representing an increase of 109% compared to revenue of $530.4 million in Q1 2017, due to the strength of the DuPont acquisition. On a pro-forma basis, the segment’s revenue increased 13% on a y-o-y basis, of which foreign exchange contributed 3% to 4% growth.

In Q1 2018, the Agricultural Solutions segment’s EBITDA soared 250% versus $101.8 million in Q1 2017 and were $51 million above the mid-point of the prior guidance range. The segment’s EBITDA margin was over 32% in the reported quarter, 270 basis points above the mid-point of the Company’s guidance.

For Q1 2018, FMC Lithium segment’s revenue surged 57% to $102.8 million compared to revenue of $65.6 million in Q1 2017. The segment’s EBITDA nearly doubled to $50.3 million in the reported quarter versus $25.8 million in the prior year’s same quarter. Higher volume from debottlenecking projects in Argentina and the hydroxide expansion in China, higher y-o-y prices on all product categories and lower operating costs were the main contributors to growth.

Outlook

FMC is forecasting adjusted earnings to be in the range of $5.90 to $6.20 per share for the full year 2018, reflecting an increase of 12% at the mid-point compared to prior guidance, and 123% higher on a y-o-y basis. The Company is expecting second quarter 2018 adjusted earnings to be in the band of $1.65 to $1.75 per share.

For the Lithium segment FMC is projecting segment revenue to be in the range of $430 million to $460 million for FY18, an increase of nearly 30% on a y-o-y basis, while the outlook for FY 2018 segment’s EBITDA is in the band of $193 million to $203 million. For Q2 2018, the Company is expecting Lithium segment’s EBITDA to be in the range of $47 million to $51 million, which represents an increase of over 75% on a y-o-y basis.

FMC raised FY18 estimates for the Agricultural Solutions segment. The segment’s FY18 revenue is now forecasted to be in the range of $4.05 billion to $4.25 billion, up 2.5% at the mid-point compared to prior guidance. The segment’s EBITDA is expected to be in the band of $1.16 billion to $1.24 billion, up $100 million at the mid-point compared to prior guidance. For Q2 2018, the Agricultural Solutions segment’s EBITDA is forecasted to be in the range of $315 million to $345 million.

FMC noted that the separate listing of FMC Lithium stock remains on track for October 2018.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, FMC’s stock advanced 1.19%, ending the trading session at $88.37.

Volume traded for the day: 788.35 thousand shares.

Stock performance in the last month – up 10.84%; previous three-month period – up 12.60%; and past twelve-month period – up 17.83%

After yesterday’s close, FMC’s market cap was at $11.89 billion.

Price to Earnings (P/E) ratio was at 26.91.

The stock has a dividend yield of 0.75%.

The stock is part of the Basic Materials sector, categorized under the Chemicals – Major Diversified industry. This sector was up 2.5% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501323

Stock Monitor: Dynasil Corp. of America Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on Garmin Ltd (NASDAQ: GRMN), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=GRMN. Garmin posted its financial results for first quarter of fiscal year 2018 (Q1 FY18) on May 02, 2018. The American multinational technology Company surpassed market estimates for revenue and earnings for first quarter 2018. Additionally, the Company maintained its guidance for fiscal 2018. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Dynasil Corp. of America (NASDAQ: DYSL), which also belongs to the Technology sector as the Company Garmin. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=DYSL

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Garmin most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=GRMN

Earnings Highlights and Summary

For the quarter ended March 31, 2018, Garmin reported record revenue of $710.9 million compared to $641.5 million in the first quarter 2017, increasing 10.8% on a y-o-y basis. The Company’s revenue number in the reported quarter exceeded analysts’ expectations of $668.8 million.

Garmin incurred cost of goods sold of $284.3 million in the reported quarter versus $268.7 million in the year ago comparable period. The Company’s gross profit and gross margin advanced to $426.5 million and 60% respectively, in Q1 FY18 in contrast to $372.8 million and 58% in Q1 FY17.

In the reported quarter, Garmin’s operating expenses increased 11% to $284.3 million versus $255.8 million in the year ago corresponding period. The Company’s operating income scaled 21.5% to $142.2 million in Q1 FY18 compared to $117.0 million in Q1 FY17.

During Q1 FY18, Garmin’s net income declined 45.7% to $129.4 million compared to $238.4 million in Q1 FY17. The Company reported diluted earnings per share (EPS) of $0.68 in Q1 FY18 in comparison to $1.26 in Q1 FY17, decreasing 46% on a y-o-y basis. The Company’s adjusted EPS jumped 30.7% to $0.68 in the reported quarter compared to $0.52 per share the year ago same period, thus surpassing market estimates of $0.56 per share.

Garmin’s Segments Details

Garmin operates through five segments: (i) Outdoor; (ii) Aviation; (iii) Marine; (iv) Auto; and (v) Fitness.

The Outdoor, Fitness, Marine, Auto and Aviation segments aggregated revenue of 20%, 23%, 16%, 20%, and 21%, respectively, in Q1 FY18 compared to 18%, 22%, 16%, 25%, and 19%, correspondingly, in Q1 FY17.

The Outdoor segment’s revenue grew by 24% to $144.3 million in the reported quarter compared to $115.9 million in prior year’s corresponding period, driven by significant contributions from demand of wearables. The segment’s operating income increased to $43.8 million in Q1 FY18 versus $34.5 million in Q1 FY17.

The Aviation segment posted revenue growth of 19% to $145.7 million in Q1 FY18 compared to $122.9 million in Q1 FY17, primarily due to higher sales of aftermarket products and positive contributions from original equipment manufacturers (OEM) products. Operating income grew to $48.4 million in the reported quarter in comparison to $38.6 million in the year-ago corresponding period.

During Q1 FY18, the Marine segment added revenue of $113.6 million compared to $104.5 million in Q1 FY17, increasing 9% on a y-o-y basis. The segment’s operating income declined to $13.1 million in the reported quarter versus $18.2 million in the comparable quarter last year.

The Auto segment recorded a revenue decline of 12% to $141.3 million in Q1 FY18 compared to $160.5 million in Q1 FY17, mainly due to the ongoing personal navigation device (PND) market contraction. The segment’s operating income decreased to $3.5 million in the reported quarter in comparison to $7.4 million in year ago same quarter.

For Q1 FY18, the Fitness segment posted 20% growth in revenue of $166.0 million versus $137.8 million in Q1 FY17, primarily driven by our advanced GPS-enabled products. The segment’s operating income increased to $33.4 million in the reported quarter compared $18.5 million in the year ago comparable period.

Cash Matters

As of March 28, 2018, Garmin’s cash and cash equivalents stood at $899.0 million compared to $891.5 million as of December 30, 2017. The Company generated net cash inflow from operating activities of $214.2 million in Q1 FY18 versus $120.4 million in Q1 FY17. In the reported quarter, the Company had free cash flow of $187.9 million compared to $94.9 million in the comparable quarter last year.

Outlook

For FY18, Garmin upheld revenue guidance of $3.2 billion and pro-forma earnings of $3.05 per share.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, Garmin’s stock was slightly up 0.76%, ending the trading session at $60.90.

Volume traded for the day: 711.91 thousand shares.

Stock performance in the last month – up 3.80%; previous three-month period – up 2.80%; past twelve-month period – up 16.87%; and year-to-date – up 2.23%

After yesterday’s close, Garmin’s market cap was at $12.06 billion.

Price to Earnings (P/E) ratio was at 19.60.

The stock has a dividend yield of 3.48%.

The stock is part of the Technology sector, categorized under the Scientific & Technical Instruments industry. This sector was up 0.9% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501324

Stock Monitor: BIOLASE Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on Hologic, Inc. (NASDAQ: HOLX), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HOLX. The Company reported its second quarter fiscal 2018 operating and financial results on May 02, 2018. The medical device maker beat revenue estimates, while its earnings were in-line with market expectations. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for BIOLASE, Inc. (NASDAQ: BIOL), which also belongs to the Healthcare sector as the Company Hologic. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=BIOL

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Hologic most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HOLX

Earnings Highlights and Summary

For the second quarter of the fiscal year 2018, Hologic’s revenues increased 10.3% to $789.3 million compared to $715.4 million in Q2 FY17. Excluding the acquired medical aesthetics and divested blood screening businesses, the Company’s revenues increased 4.8%, or 2.6% in constant currency. Hologic’s revenue numbers exceeded analysts’ estimates of $780.1 million.

During Q2 FY18, Hologic’s gross margin was 52.6% on a GAAP basis, and 62.7% on a non-GAAP basis. The Company’s GAAP gross margin declined by 170 basis points, while its non-GAAP gross margin declined by 120 basis points, primarily due to geographic and product sales mix.

For Q2 FY18, Hologic’s operating expenses were $1.02 billion on a GAAP basis compared to negative $611.1 million in Q2 FY17; increasing primarily due to the Cynosure impairment charges compared to a gain of $899.7 million from the sale of the Company’s blood screening business in the prior year’s same period. On a non-GAAP basis, Hologic’s operating expenses increased 19.7% to $266.9 million.

Hologic’s GAAP net loss was $681.4 million, or $2.46 per diluted share, in Q2 FY18 compared to a net income of $526.8 million, or $1.84 per diluted share, in Q2 FY17, declining primarily due to non-cash impairment charges for goodwill and in-process research and development (R&D) of $685.7 million and $46.0 million, respectively, related to Hologic’s Cynosure business, and the gain on the sale of the Company’s blood screening business in the prior year’s comparable period.

Hologic’s non-GAAP earnings jumped 6.0% to $0.53 per diluted share in Q2 FY18 compared to $0.50 per diluted share in Q2 FY17. The Company’s earnings were in-line with Wall Street’s estimates of $0.53 per share.

Revenue Details

During Q2 FY18, Hologic’s US revenues rose 3.3% to $588.5 million on a y-o-y basis. Excluding the acquired medical aesthetics and divested blood screening businesses, the Company’s US revenues decreased slightly. The Company’s International revenues surged 37.8% to $200.8 million on a y-o-y basis in the reported quarter. Excluding the acquired medical aesthetics and divested blood screening businesses, the Company’s International revenues increased 26.4% in the reported quarter.

For Q2 FY18, Hologic’s Breast Health revenues totaled $300.1 million, reflecting an increase of 7.0% on a y-o-y basis, driven by strong international sales, new products, and service revenues.

In its Diagnostics segment, Hologic’s GYN Surgical revenues fell 1.7% to $99.4 million on a y-o-y basis. The Company’s MyoSure® revenues jumped 13.5% to $52.7 million compared to the year ago corresponding period, while NovaSure® revenues declined 14.5% to $46.7 million on a y-o-y basis.

Hologic’s Medical Aesthetics segment generated revenues of $85.5 million in Q2 FY18, reflecting an increase of 11.5% compared to pro-forma net sales of $76.7 million in Q2 FY17, during the majority of which Cynosure was an independent Company.

For Q2 FY18, Hologic’s Skeletal Health revenues increased 12.6% to $24.6 million compared to $21.8 million in Q2 FY17.

Financial Position

During Q2 FY18, Hologic repurchased 2.8 million shares of its common stock for $106.5 million.

Hologic’s total debt outstanding was $3.4 billion at the end of Q2 FY18. As of March 31, 2018, the Company had cash and equivalents of $0.6 billion, and a net leverage ratio of 2.7 times.

On a trailing 12-month basis, the Company’s adjusted return on invested capital (ROIC) declined 60 basis points to 12.6% versus the prior year’s comparable period.

Outlook

For the full fiscal year 2018, Hologic is forecasting revenues to range from $3.18 billion to $3.21 billion, with reported growth rates between 4.0% and 4.9%. The Company re-affirmed its earnings per diluted share to be in the band of $2.22 to $2.27, which represents a reported growth of between 9.4% and 11.8%.

For the third quarter of the fiscal year 2018, Hologic is projecting revenues between $795 million and $810 million, which reflects a decline of 2.8% to a decline of 1% on a constant currency basis. On the bottom-line, the Company expect earnings per share of $0.55 to $0.57 for Q3 FY18, which implies growth rates of between 10% and 14%.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, Hologic’s stock climbed 1.14%, ending the trading session at $39.02.

Volume traded for the day: 1.39 million shares.

Stock performance in the last month – up 0.59%; and previous three-month period – up 0.49%

After yesterday’s close, Hologic’s market cap was at $10.81 billion.

The stock is part of the Healthcare sector, categorized under the Medical Instruments & Supplies industry. This sector was up 1.4% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501326

Stock Monitor: Leju Holdings Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on Kennedy-Wilson Holdings, Inc. (NYSE: KW), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=KW as the Company’s latest news hit the wire. On May 29, 2018, the Company announced that it has sold a six-property multifamily portfolio totaling 2,199 units, for approximately $422 million. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Leju Holdings Limited (NYSE: LEJU), which also belongs to the Financial sector as the Company Kennedy-Wilson Holdings. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=LEJU

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Kennedy-Wilson Holdings most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=KW

Asset Sales Generated Cash Proceeds of $223 Million

The asset sales generated cash proceeds of $223 million for Kennedy-Wilson, and for its commingled funds and equity partners, including net proceeds to the Company of approximately $104 million. The Company had a 41.3% average ownership in the six properties. For the full fiscal year, Kennedy-Wilson completed $202 million in multifamily acquisitions, totaling 956 units in the Western US and Ireland. The Company also has 2,530 multifamily units under development or in design.

Property Details

The six garden-style apartment communities were originally built between 1989 and 1999, and have undergone improvement plans including exterior renovations and unit upgrades under Kennedy-Wilson’s ownership. Located across four states, the properties in the portfolio include Slate Creek in Roseville, CA with 612 units; Xander 3900 in the Las Vegas Valley with 480 units; Big Trout Lodge in the City of Liberty Lake, WA with 297 units; Heatherbrae Commons in Milwaukie, OR with 174 units; Montair at Somerset Hill in Tumwater, WA with 396 units; and StonePointe in University Place, WA with 240 units.

Portfolio Sale Enables Kennedy-Wilson to Recycle Capital into Other Strategic Investment Opportunities

Commenting on the announcement, William J. McMorrow, Chairman and Chief Executive Officer (CEO) of Kennedy-Wilson, stated that this portfolio sale enables the Company to recycle capital into other strategic investment opportunities. McMorrow added that these six properties represent the successful roll-out of Kennedy-Wilson’s value-add asset management initiatives, and the Company is pleased to see those efforts create compelling value for its investors.

Kennedy-Wilson and AXA Investment Managers – Real Assets Irish PRS Joint Venture

On May 08, 2018, Kennedy-Wilson and AXA Investment Managers – Real Assets (“AXA”), which is a global leader in real asset investments and the leading real estate portfolio and asset manager in Europe, entered into a joint venture (JV) targeting the Irish Private Rented Sector (PRS). The JV with AXA, on behalf of its clients, was expected to commence with 1,173 units across three of Kennedy-Wilson’s Dublin PRS schemes, namely Alliance, Clancy Quay, and Sandford Lodge. These were premier PRS assets in prime city-center and suburban Dublin locations. Kennedy-Wilson would continue to hold its current 50% interest in the three assets. The JV would seek PRS development and investment opportunities across Ireland, targeting Dublin and other large urban centers. Kennedy-Wilson would act as overall asset manager for the JV.

About Kennedy-Wilson Holdings, Inc.

Founded in 1977 and headquartered in Beverly Hills, California, Kennedy-Wilson is a global real estate investment Company, owning, operating, and investing in real estate on its own and through its investment management platform. Kennedy-Wilson focuses on multifamily and commercial properties located in the Western US, the UK, Ireland, Spain, Italy, and Japan.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, Kennedy-Wilson’s stock rose 2.28%, ending the trading session at $20.20.

Volume traded for the day: 615.10 thousand shares.

Stock performance in the last month – up 6.60%; previous three-month period – up 23.55%; past twelve-month period – up 3.59%; and year-to-date – up 16.43%

After yesterday’s close, Kennedy-Wilson’s market cap was at $2.93 billion.

Price to Earnings (P/E) ratio was at 55.04.

The stock has a dividend yield of 3.76%.

The stock is part of the Financial sector, categorized under the Property Management industry. This sector was up 1.6% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501328

LONDON, UK / ACCESSWIRE / May 31, 2018 / Active-Investors has a free review on NIKE, Inc. (NYSE: NKE) following the Company’s announcement that it will begin trading ex-dividend on June 01, 2018. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on May 31, 2018. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on NKE:

www.active-investors.com/registration-sg/?symbol=NKE

If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:

www.active-investors.com/registration-sg

Dividend Declared

On May 10, 2018, NIKE announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share on the company’s outstanding Class A and Class B Common Stock payable on July 05, 2018, to shareholders of record at the close of business on June 04, 2018.

Nike’s indicated dividend represents a yield of 1.11% compared to the average dividend yield of 1.95% for the Consumer Goods sector.

Dividend Insights

Nike has a dividend payout ratio of 34.2%, which indicates that the Company spends approximately $0.34 for dividend distribution out of every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts’ estimates, Nike is forecasted to report earnings of $2.69 per share for the next year, which is more than three times higher than the Company’s annualized dividend of $0.80 per share.

As of February 28, 2018, Nike’s cash and cash equivalents totaled $3.66 billion compared to cash and cash equivalents of $3.81 billion as on February 28, 2017. For the nine months ended February 28, 2018, the Company’s cash provided in operating activities totaled $2.69 billion compared to $2.88 billion used in the prior year’s same period. The Company’s financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.

About NIKE, Inc.

NIKE is the world’s leading designer, marketer, and distributor of authentic athletic footwear, apparel, equipment, and accessories for a wide variety of sports and fitness activities. Wholly-owned NIKE subsidiary brands include Converse, which designs, markets and distributes athletic lifestyle footwear, apparel and accessories; and Hurley, which designs, markets and distributes surf and youth lifestyle footwear, apparel and accessories.

NIKE was founded in 1964 and is headquartered in Beaverton, Oregon.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, NIKE’s stock climbed 1.85%, ending the trading session at $72.23.

Volume traded for the day: 5.79 million shares.

Stock performance in the last month – up 5.61%; previous three-month period – up 7.76%; past twelve-month period – up 36.49%; and year-to-date – up 15.48%

After yesterday’s close, NIKE’s market cap was at $116.30 billion.

Price to Earnings (P/E) ratio was at 31.24.

The stock has a dividend yield of 1.11%.

The stock is part of the Consumer Goods sector, categorized under the Textile – Apparel Footwear & Accessories industry. This sector was up 0.9% at the end of the session.

—

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501305

LONDON, UK / ACCESSWIRE / May 31, 2018 / Active-Investors has a free review on Northrop Grumman Corp. (NYSE: NOC) following the Company’s announcement that it will begin trading ex-dividend on June 01, 2018. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on May 31, 2018. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on NOC:

www.active-investors.com/registration-sg/?symbol=NOC

If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:

www.active-investors.com/registration-sg

Dividend Declared

On May 15, 2018, Northrop Grumman’s Board of Directors declared a quarterly dividend of $1.20 per share on Northrop Grumman’s common stock, a 9% increase from the prior quarterly dividend of $1.10 per share. The dividend is payable June 20, 2018, to shareholders of record as of the close of business June 04, 2018.

Northrop Grumman’s indicated dividend represents a yield of 1.45%, which is substantially higher than the average dividend yield of 1.14% for the Industrial Goods sector. The Company has raised dividend for 10 years in a row.

Dividend Insights

Northrop Grumman has a dividend payout ratio of 30.2%, which means that the Company spends approximately $0.30 for dividend distribution out of every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts’ estimates, Northrop Grumman is forecasted to report earnings of $17.42 per share for the next year, which is more than three times higher compared to the Company’s annualized dividend of $4.80 per share.

As of March 31, 2018, Northrop Grumman had approximately $10.37 billion in cash and cash equivalents compared to December 31, 2017, when the Company had $11.23 billion in cash and cash equivalents. The Company’s cash used in operating activities totaled $237 million in Q1 2018 compared to $439 million used in the prior year’s same period. Northrop Grumman’s net use of cash during Q1 2018 was consistent with the Company’s historical timing of operating cash flows, which are generally more heavily weighted toward the second half of the fiscal year. The Company’s financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.

About Northrop Grumman Corp.

Northrop Grumman is a leading global security company providing innovative systems, products and solutions in autonomous systems, cyber, C4ISR, strike, and logistics and modernization to customers worldwide.

Northrop Grumman was founded in 1939 and is based in Falls Church, Virginia.

Stock Performance Snapshot

May 30, 2018 – At Wednesday’s closing bell, Northrop Grumman’s stock climbed 1.56%, ending the trading session at $331.57.

Volume traded for the day: 733.10 thousand shares.

Stock performance in the last month – up 2.96%; previous six-month period – up 9.20%; past twelve-month period – up 29.41%; and year-to-date – up 8.03%

After yesterday’s close, Northrop Grumman’s market cap was at $57.98 billion.

Price to Earnings (P/E) ratio was at 24.10.

The stock has a dividend yield of 1.45%.

The stock is part of the Industrial Goods sector, categorized under the Aerospace/Defense – Major Diversified industry. This sector was up 1.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 501306